Subtype
Ovarian Neoplasm
CI-CAN-00001335Explore in graph →
Non-malignant746 active trials5 approved drugs94 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001335Explore in graph →
Clinical trials
3,430 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00735150 | Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk | completed | — | 34 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 11, 2010 | clinicaltrials |
| NCT00277160 | A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer | completed | Phase 4 | 852 | AmgenINDUSTRY | 0 | Oct 8, 2010 |
| clinicaltrials |
| NCT00097409 | Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer | completed | Phase 2 | 35 | GlaxoSmithKlineINDUSTRY | 1 | Oct 4, 2010 | clinicaltrials |
| NCT00002508 | Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors | completed | Phase 1 / Phase 2 | — | Temple UniversityOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT00531570 | Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma | completed | — | 100 | NYU Langone HealthOTHER | 1 | Sep 23, 2010 | clinicaltrials |
| NCT00082654 | Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients | completed | N/A | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00217529 | Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer | completed | Phase 1 / Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00217555 | Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00217568 | Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00002977 | Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission | completed | Phase 1 | 45 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 15, 2010 | clinicaltrials |
| NCT00003080 | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer | completed | Phase 1 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 15, 2010 | clinicaltrials |
| NCT00900679 | Effects of a Teaching Intervention With an Advanced Practice Nurse on Quality of Life and Psychosocial and Symptom Distress in Patients With Ovarian Cancer | completed | N/A | 110 | City of Hope Medical CenterOTHER | 1 | Aug 11, 2010 | clinicaltrials |
| NCT00648102 | Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer(CDX1307-02) | completed | Phase 1 | 36 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00709462 | A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) | completed | Phase 1 | 48 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00109993 | Campath-1H + FK506 and Methylprednisolone for GVHD | completed | Phase 2 | 34 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT01124435 | Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients(carbo-cox2) | completed | Phase 2 | 45 | Catholic University of the Sacred HeartOTHER | 1 | Jun 4, 2010 | clinicaltrials |
| NCT00410657 | Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant | completed | Phase 2 | 53 | Fred Hutchinson Cancer CenterOTHER | 1 | May 14, 2010 | clinicaltrials |
| NCT00101257 | Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer | completed | Phase 1 | 18 | Fred Hutchinson Cancer CenterOTHER | 1 | May 7, 2010 | clinicaltrials |
| NCT00063401 | Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer | completed | Phase 2 | 39 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 8, 2010 | clinicaltrials |
| NCT00004157 | Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00010283 | Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon | completed | Phase 1 / Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00098800 | Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries | completed | N/A | 40 | University of ArizonaOTHER | 1 | Mar 24, 2010 | clinicaltrials |
| NCT00261027 | Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer | completed | Phase 2 | 30 | Ottawa Hospital Research InstituteOTHER | 1 | Mar 2, 2010 | clinicaltrials |
| NCT00160472 | Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms | completed | N/A | 110 | United States Department of DefenseFED | 1 | Feb 26, 2010 | clinicaltrials |
| NCT00291837 | CT-2106 for the Second Line Treatment of Ovarian Cancer | completed | Phase 2 | 40 | CTI BioPharmaINDUSTRY | 3 | Feb 26, 2010 | clinicaltrials |
| NCT00239980 | Fragmin in Ovarian Cancer: Utility on Survival (FOCUS) | completed | Phase 2 | 77 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Feb 3, 2010 | clinicaltrials |
| NCT00944944 | Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema | completed | — | 58 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 1, 2010 | clinicaltrials |
| NCT00002901 | Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00164658 | Evaluating Tools for Health Promotion and Disease Prevention | completed | Phase 1 | 8,400 | Centers for Disease Control and PreventionFED | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00461786 | A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer | completed | Phase 2 | 51 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 4, 2009 | clinicaltrials |
| NCT00608452 | Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers | completed | — | 121 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 13, 2009 | clinicaltrials |
| NCT00772863 | Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer(Tax-Over) | completed | Phase 2 | 37 | SanofiINDUSTRY | 1 | Oct 29, 2009 | clinicaltrials |
| NCT00465725 | A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors | completed | Phase 1 | 18 | Poniard PharmaceuticalsINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00582322 | Genetic Studies in Breast Cancer | completed | — | 483 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 20, 2009 | clinicaltrials |
| NCT00034151 | Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer | completed | Phase 2 | 52 | Achieve Life SciencesINDUSTRY | 0 | Jun 4, 2009 | clinicaltrials |
| NCT00120939 | Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer | completed | Phase 1 | 25 | Pharmacyclics LLC.INDUSTRY | 1 | Apr 3, 2009 | clinicaltrials |
| NCT00191334 | Gemcitabine in Ovarian Cancer | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Mar 27, 2009 | clinicaltrials |
| NCT00291473 | Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers | completed | Phase 1 | 9 | Ludwig Institute for Cancer ResearchOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00596349 | Women Surviving Ovarian Cancer | completed | — | 62 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 26, 2009 | clinicaltrials |
| NCT00204633 | Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP) | completed | Phase 2 | 108 | University Hospital TuebingenOTHER | 1 | Feb 16, 2009 | clinicaltrials |
| NCT00113789 | Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer | completed | Phase 2 | 21 | AmgenINDUSTRY | 0 | Feb 13, 2009 | clinicaltrials |
| NCT00315861 | Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies | completed | Phase 1 | 15 | SCRI Development Innovations, LLCOTHER | 1 | Jan 23, 2009 | clinicaltrials |
| NCT00400348 | Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer | completed | Phase 2 | 18 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2008 | clinicaltrials |
| NCT00069901 | Phase II CT-2103/Carboplatin in Ovarian Cancer | completed | Phase 2 | 82 | CTI BioPharmaINDUSTRY | 1 | Sep 22, 2008 | clinicaltrials |
| NCT00338026 | A Phase I Study of ECO-4601 in Patients With Advanced Cancer | completed | Phase 1 | 26 | Thallion PharmaceuticalsINDUSTRY | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00436189 | Assess Cancer in Ovarian Tumors With Biomarkers. | completed | N/A | 1,000 | Ciphergen BiosystemsINDUSTRY | 1 | Apr 30, 2008 | clinicaltrials |
| NCT00655447 | Examining the Long-Term Risks of Oophorectomy | completed | — | 32,175 | Parker, William H., M.D.OTHER | 1 | Apr 9, 2008 | clinicaltrials |
| NCT00001272 | A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001302 | A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
Data updated 23 days agoSource updated Oct 11, 2010source: clinicaltrials